Viewing StudyNCT00359879



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00359879
Status: COMPLETED
Last Update Posted: 2015-02-23
First Post: 2006-08-01

Brief Title: Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes
Keywords:
Name View
Amylin View
diabetes View
exenatide View
Lilly View